Welcome to New Mobility’s weekly newsletter. To receive via email (mobile-friendly), subscribe here.
Stem Cells, Inc. shocked SCI and research communities when it announced that it has closed its Pathway trial using adult neural stem cells. New Mobility reported June 1 on its encouraging results, which included improved hand function for quads, improved sensation and bladder awareness. The company’s lead medical officer had just told NM that the trials would be enrolling through September when the board of directors decided the reported improvements were “not big enough” for investors.